Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Third Wave s Invader Occupies Microarray Platform

NEW YORK, Aug. 21 – Third Wave Technologies and researchers from two academic centers in the US have applied the company’s Invader SNP-detection technology to a microarray platform, Third Wave said on Tuesday.

Applying the Invader technology onto a bead, chip or other microarray format will allow Third Wave to market to scientists performing highly multiplexed analyses, the company said in a statement.

The application, perfected by Third Wave and researchers at Northwestern University and the University of Wisconsin-Madison and detailed in the current issue of Nucleic Acids Research Methods Online , “extends the scalability and market potential of the platform,” Lance Fors, Third Wave’s chairman and CEO, said in the statement.

A spokesman for Third Wave said that it took the company and its university partners roughly one year to show that the Invader technology can be applied to a microarray platform. Third Wave plans to report its findings at the 51st annual meeting of the American Society of Human Genetics in October, he added. 

He could not say when the technology would be ready for commercialization.

Last month, Third Wave said that sales of its Invader SNP analysis system boosted second-quarter revenues to $8.7 million from $800,000 in the year-ago period. 

Based on demand for its Invader DNA and RNA products, the company said it expects revenues to reach at least $6 million in the third quarter and $32 million for the year. 

Third Wave, based in Madison, Wisc., also said in July that it had established an internal bioinformatics department that will annotate genome sequences targeted by the Invader system. 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.